Ophthalmic Goods

Ophthalmic Goods companies under SIC 3851 manufacture and distribute prescription lenses, frames, contact lenses, intraocular implants, surgical instruments, diagnostic imaging systems, and related consumables for optometrists, ophthalmologists, ambulatory surgery centers, and optical retailers. Growth is supported by aging populations, rising myopia, and premiumization in coatings and toric/multifocal designs, while 2024-2025 trends focus on AI-enabled diagnostics, tele-optometry integrations, sustainable bio-based materials, and early-stage smart glasses and AR vision aids. The sector faces tight oversight from FDA medical device classifications, ISO quality standards, and reimbursement pressures, with risks tied to supply chain concentration, product recalls, clinical data requirements, and shifting payer policies on vision benefits. Makers increasingly offer service models—fitting software, cloud analytics, and practice-management tie-ins—to secure recurring revenue. For investors and operators tracking competitive positioning, regulatory updates, and unit economics, view live SEC filings on EarningsFeed to monitor disclosures and real-time momentum.

Source: Earnings Feed research · last fetched 11/23/2025